Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery

NCT00669734 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

NIH

Sponsor class

Conditions

Locally Advanced Pancreatic Adenocarcinoma
Pancreatic Acinar Cell Carcinoma
Pancreatic Ductal Adenocarcinoma
Stage III Pancreatic Cancer AJCC v6 and v7
Stage IV Pancreatic Cancer AJCC v6 and v7

Interventions

BIOLOGICAL: Falimarev
BIOLOGICAL: Inalimarev
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Sargramostim

Sponsor

National Cancer Institute (NCI)